Thane: Fermenta Biotech Limited (BSE: 506414) (Bloomberg: FERMENTA:IN) (Reuters: FERM.BO), an Indian manufacturer of active pharmaceutical ingredients (APIs), intermediates, and nutritional premixes, has announced that the Indian Patent Office has officially granted a patent for its in-house developed plant-based Vitamin D3 process.
The newly granted patent secures Fermenta Biotech’s proprietary process for producing plant-based Vitamin D3, representing a major advancement in its innovation pipeline.
This breakthrough reinforces the company’s position as a global leader in the Vitamin D3 domain, particularly with vegan and vegetarian-friendly alternatives, as consumer demand for sustainable, ethically sourced nutrition continues to accelerate.
Also Read: Manufacturing Innovation: Godrej Tooling Secures Three New Patents
Fermenta Biotech: Supporting Vegan and Sustainable Vitamin D3 Solutions
By enabling the commercial production of 100% plant-based Vitamin D3, Fermenta Biotech is set to address emerging opportunities in nutraceuticals and food fortification.
Plant-derived ingredients are gaining significant traction worldwide, commanding premium value in the nutrition sector due to their sustainability and ethical sourcing.
Prashant Nagre, Managing Director of Fermenta Biotech, commented: “The grant of this patent is a proud milestone in our journey of innovation. It reflects our commitment to delivering environmentally conscious solutions that align with evolving consumer needs.
Plant-based Vitamin D3 represents the future of nutrition, and this patent strengthens our ability to create differentiated offerings that generate long-term value for our partners and society at large. It also underscores India’s potential as a hub for pioneering industrial innovation in global wellness.”
Also Read: Biostate AI Secures Global Collaborations to Advance RNA-Based Precision Medicine
Expanding Fermenta Biotech’s Innovation Legacy
This patent not only fortifies Fermenta Biotech’s competitive advantage but also builds upon its pioneering legacy in biotechnology and nutrition.
With its expanding portfolio – including Customized Premixes, Fortified Rice Kernel (FRK), and other nutritional ingredients – the company continues to contribute toward closing global nutrition gaps while upholding its principles of sustainability and scientific excellence.
Founded in 1951, Fermenta Biotech Limited is a leading innovator in nutrition, APIs, and premixes, with a strong emphasis on sustainable and plant-based solutions for global markets.
